News
VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company”) announced that it has emerged from stealth mode to dramatically impact drug discovery and development. VivoSim will offer liver and intestinal ...
VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company") announced that it has emerged from stealth mode to dramatically impact drug discovery and development.
Diarrhea Diarrhea was the most common adverse reaction in two randomized, double-blind, placebo-controlled trials of IBS-C. Severe diarrhea was reported in 2.5% of IBSRELA-treated patients. If severe ...
As the Shenzhou-20 manned spacecraft and the Long March-2F Y20 carrier rocket stand ready at the launch site on ...
The Shenzhou-20 crewed spaceship, atop a Long March-2F carrier rocket, blasts off from the Jiuquan Satellite Launch Center in ...
As digital replicas of real people become more common in image-based industries like fashion, urgent questions are emerging ...
Health, the leading global mental health solution for employers and health plans, today unveiled its principled approach to artificial intelligence (AI)?establishing a new industry benchmark for how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results